This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Multiline Insurers Worth Buying Despite Industry Challenges
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, HIG, EG and MTG.
Should You Buy Everest Group (EG) for Better Returns Now?
by Zacks Equity Research
Everest Group (EG) stands to gain from new business growth, strong renewal retention, continued favorable rate increases and a solid capital position.
Everest Group (EG) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Everest Group (EG) could produce exceptional returns because of its solid growth attributes.
Everest Group (EG) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Everest Group (EG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Everest Group (EG) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Stocks With Recent Dividend Hike in a Volatile September
by Nalak Das
Dividend-paying stocks should be in demand as investors try to safeguard their portfolios. Five such stocks are: PECO, VZ, FITB, EG, IDCC.
EG vs. MURGY: Which Stock Is the Better Value Option?
by Zacks Equity Research
EG vs. MURGY: Which Stock Is the Better Value Option?
Here's Why Hold Strategy is Apt for Prudential Financial (PRU)
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from higher emerging markets earnings, improved spread income, strategic acquisitions, effective capital deployment and a solid financial position.
MetLife (MET) Unveils Solutions to Boost Footprint in Asia
by Zacks Equity Research
MetLife (MET) launches 360Health in Nepal and 360Future in Korea to empower its clients to effectively manage their health conditions and enjoy a happy retirement life.
Radian (RDN) Up 35% YTD: Should You Buy It for Better Return?
by Zacks Equity Research
Radian (RDN) is poised to gain from improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment, a solid capital position and effective capital deployment.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Hold Strategy Is Apt for Assurant (AIZ) Stock Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from increasing Global Automotive business, higher average insured values, improved invested assets, favorable growth estimates and effective capital deployment.
MGIC Investment (MTG) Rises 31.6% YTD: More Room to Run?
by Zacks Equity Research
MGIC Investment (MTG) stock rallies on the back of higher insurance in force, a decline in loss and claims payments, better housing market fundamentals and a solid capital position.
3 Value Stocks to Bet on From Undervalued Insurance Space
by Sushmita Sarker
Riding on product diversification, better pricing, favorable reserve development and solid capital position, undervalued insurers like AXS, RDN and EG are poised to fetch better returns.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from an improvement in continued shift in the mix of underlying products toward higher value policies and installment fees and a robust capital position.
3 Reasons Growth Investors Will Love Everest Group (EG)
by Zacks Equity Research
Everest Group (EG) could produce exceptional returns because of its solid growth attributes.
EverQuote (EVER) Up 6.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Has Everest Group, Ltd. (EG) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Everest Group (EG) and Midwest Holding Inc. (MDWT) have performed compared to their sector so far this year.
Why Everest Group (EG) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Everest Group (EG) Stock Rises 10% YTD: More Upside Left?
by Zacks Equity Research
New business growth, strong renewal retention, continued favorable rate increases and a solid capital position continue to drive Everest Group (EG).
Why Is Assurant (AIZ) Down 2.6% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO (CNO) Down 4.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Lincoln National (LNC) Adds Features to Variable Annuity Suite
by Zacks Equity Research
Lincoln National (LNC) attaches two new crediting strategies to its indexed variable annuity product, Lincoln Level Advantage, to offer growth opportunities to investors regardless of market performance.
Here is Why Growth Investors Should Buy Everest Group (EG) Now
by Zacks Equity Research
Everest Group (EG) is well positioned to outperform the market, as it exhibits above-average growth in financials.